Business model and Organisational chart
Innovation, scientific competence and the defence of intellectual property. These are the cornerstones of the PharmaNutra Group, which are also reflected in its business model and organisation chart.
A commercial approach driven by market performance but based on:
- Flexibility and responsiveness
- Continuous training
- Competitive time to market
The Group’s commercial structure was built to respond to the peculiarities of the domestic market but has been able to adapt quickly and efficiently to international requirements.
PharmaNutra currently has more than 90 employees in Italy and a network of over 154 PSRs (Pharmaceutical Sales Representatives), who are the real driving force of the company in the territory. A far-reaching network divided into three specific sales lines, Primary, Supportive and Nutrition, each one with its own manager reporting directly to the Commercial Director.
Since 2013, PharmaNutra has operated in foreign markets with a flexible and innovative business model, based on a consolidated network of top-class distributors. The Group’s products are currently distributed in 87 countries around the world, including Europe, Asia, Africa and America, thanks to a network of 58 carefully selected sales partners.
In order to meet the strategic needs related to internationalisation projects, two new wholly owned subsidiaries were established in 2023: PharmaNutra USA and PharmaNutra España, dedicated to the marketing of PharmaNutra branded products, both through online e-commerce channels and through direct distribution in the territory.
2024 will see the merger by incorporation of the Group’s two other important companies, Junia Pharma S.r.l. and Alesco S.r.l., a fundamental step towards the establishment of a new corporate structure to meet the requirements of the entire production chain, from the development of new technologies and patents to marketing innovative raw materials and proprietary finished products.
